When Should You Buy dormakaba Holding AG (VTX:DOKA)?
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.
According to our price multiple model, which makes a comparison between the company's price-to-earnings ratio and the industry average, the stock price seems to be justfied. In this instance, we've used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock's cash flows. We find that dormakaba Holding's ratio of 46.86x is trading slightly above its industry peers' ratio of 44.1x, which means if you buy dormakaba Holding today, you'd be paying a relatively sensible price for it. And if you believe dormakaba Holding should be trading in this range, then there isn't really any room for the share price grow beyond the levels of other industry peers over the long-term. So, is there another chance to buy low in the future? Given that dormakaba Holding's share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us an opportunity to buy later on. This is based on its high beta, which is a good indicator for share price volatility.
Check out our latest analysis for dormakaba Holding
Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. dormakaba Holding's earnings over the next few years are expected to increase by 99%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.
Are you a shareholder? It seems like the market has already priced in DOKA's positive outlook, with shares trading around industry price multiples. However, there are also other important factors which we haven't considered today, such as the financial strength of the company. Have these factors changed since the last time you looked at DOKA? Will you have enough conviction to buy should the price fluctuate below the industry PE ratio?
Are you a potential investor? If you've been keeping tabs on DOKA, now may not be the most advantageous time to buy, given it is trading around industry price multiples. However, the optimistic forecast is encouraging for DOKA, which means it's worth further examining other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.
So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. For example - dormakaba Holding has 2 warning signs we think you should be aware of.
If you are no longer interested in dormakaba Holding, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
Benfica in talks with Wolfsburg for Mohamed Amoura!
The Portuguese newspaper Record reports that Benfica has set its sights on Algerian international Mohamed Amoura to strengthen its attacking lineup during this summer transfer window. Mohamed Amoura is making headlines in Record, which confirms Benfica's strong interest in the player, thanks to his technical skills and standout performances with his German club. Benfica wants to strengthen its attack with Amoura! Originally from Jijel, Amoura shone last season, netting 10 goals and providing 12 assists in 34 matches. This versatile forward has impressed head coach Bruno Lage and sporting director Rui Costa, both convinced he can make a real difference for the team. Despite Wolfsburg's hefty asking price of 40 million euros, Benfica plans to submit an official offer to finalize the deal, knowing the German club had signed the player just a year ago for only 18 million euros. According to Record, if the deal goes through, it would become the most expensive transfer in the Portuguese club's history.
Yahoo
28 minutes ago
- Yahoo
Getafe agree £10m Sunderland sale
La Liga outfit Getafe have early this week agreed on the sale of a member of the club's defensive ranks to Premier League side Sunderland. The player in question? Omar Alderete. Alderete, for his part, is a 28-year-old Paraguayan international, who has been plying his trade on the books of Getafe since the summer of 2023. Across the time since, the stopper – who chiefly operates in a central role but is also capable of filling in at left-back – managed to establish himself as a leading figure in the Azulones' backline. With such form, though, comes inevitable outside interest. And as alluded to above, this week, as much has culminated in Alderete being lured away from the Estadio Coliseum. As per a report from transfer insider Fabrizio Romano: 'Omar Alderete to Sunderland, here we go! Deal sealed with Getafe for £10m fee. Contract until June 2029. All done.' Conor Laird – GSFN
Yahoo
28 minutes ago
- Yahoo
Hiscox appoints Harriet Turner to lead SML cover
Global specialist insurer Hiscox has appointed Harriet Turner to lead new sexual molestation liability (SML) cover in its London Market business. The new offering will provide coverage for claims related to sexual misconduct within the workplace. Turner's experience encompasses various roles including underwriting at Beazley and managing different classes of business including employment practices liability and private directors and officers. The SML cover is designed to address the specific risks of sexual misconduct allegations for employees, offering a safeguard for global "large organisations" across diverse sectors, including but not limited to health, social care, leisure and financial services. The coverage extends to the costs associated with legal proceedings and any financial settlements or damages awarded during the policy period. Furthermore, Hiscox has partnered with Control Risks, a global risk consultancy, to provide additional services to SML clients. These services include evaluations of the organisation's risk management and compliance strategies before the policy is bound, with recommendations for any necessary enhancements. Turner is scheduled to start her new role within the Hiscox London Market General Liability team in September 2025, operating from the London office. Hiscox London Market's casualty divisional director Colin Buchanan said: 'Expanding into sexual molestation liability broadens out our existing liability offering and responds to an increasing demand for this type of cover from clients and brokers. 'We look forward to welcoming Harriet to the team, whose background in underwriting liability products will establish Hiscox as a go-to market for sexual molestation liability protection.' In June, Hiscox rolled out a new Cargo API solution to facilitate the underwriting process for small cargo and stock throughout risks. "Hiscox appoints Harriet Turner to lead SML cover " was originally created and published by Life Insurance International, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data